Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 1/2024

01-12-2024 | Laser | Review

Subthreshold micropulse diode laser treatment in diabetic macular edema: biological impact, therapeutic effects, and safety

Authors: Jing Hao Mei, Zhong Lin

Published in: International Ophthalmology | Issue 1/2024

Login to get access

Abstract

Purpose

To introduce the treatment of diabetic macular edema (DME) with subthreshold micropulse diode laser (SMPL), to summarize the biological impact, therapeutic effects, and safety of this treatment, and to discuss the response to DME when SMPL is combined with anti-vascular endothelial growth factor (anti-VEGF) or steroid.

Methods

The literature search was performed on the PubMed database, with a selection of English-language articles published from 2000 to 2023 with the following combinations of search terms: diabetes macular (o) edema, micropulse laser or subthreshold micropulse laser, anti-vascular endothelial growth factor, and steroid.

Results

SMPL is a popular, invisible retinal laser phototherapy that is inexpensive, safe, and effective in the treatment of DME. It can selectively target the retinal pigment epithelium, reduce the expression of pro-inflammatory factors, promote the absorption of macular edema, and exert a similar and lasting clinical effect to traditional lasers. No significant difference was found in the therapeutic effects of SMPL between different wavelengths. However, HbA1c level and pretreatment central macular thickness (CMT) may affect the therapeutic outcomes of SMPL.

Conclusion

SMPL has a slow onset and produces lasting clinical effects similar to conventional photocoagulation. It has been reported that SMPL combined with the intravitreal anti-VEGF injection can significantly reduce the number of injections without influencing the therapeutic effect, which is essential for clinical applications and research. Although 577 nm SMPL is widely used clinically, there are no standardized protocols for SMPL. Additionally, some important problems regarding the treatment of SMPL require further discussion and exploration.
Literature
1.
Wu Y et al (2018) Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: a Bayesian network meta-analysis. Biomed Pharmacother 97:293–299PubMedCrossRef
2.
3.
Klein R et al (2009) The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 116(3):497–503PubMedCrossRef
4.
Klein R et al (1995) The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 102(1):7–16PubMedCrossRef
5.
Photocoagulation for diabetic macular edema (1985) Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 103(12): 1796–806.
6.
Vujosevic S, Midena E (2015) Controversies in pharmacological treatment of inflammatory component of macular edema. Curr Pharm Des 21(32):4688–4693PubMedCrossRef
7.
8.
Citirik M (2019) The impact of central foveal thickness on the efficacy of subthreshold micropulse yellow laser photocoagulation in diabetic macular edema. Lasers Med Sci 34(5):907–912PubMedCrossRef
9.
Boyer DS et al (2015) Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials. Ophthalmology 122(12):2504–13.e1PubMedCrossRef
10.
Nguyen QD et al (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789–801PubMedCrossRef
11.
Yilmaz T et al (2009) Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 116(5):902–913PubMedCrossRef
12.
Qi HP et al (2012) Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Curr Eye Res 37(12):1136–1147PubMedCrossRef
13.
Augustin AJ et al (2015) Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol 15:150PubMedPubMedCentralCrossRef
14.
Boyer DS et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10):1904–1914PubMedCrossRef
15.
Frizziero L, Calciati A, Torresin T, Midena G, Parrozzani R, Pilotto E, Midena E (2021) Diabetic macular edema treated with 577-nm subthreshold micropulse laser: a real-life, long-term study. J Personal Med 11(5):405CrossRef
16.
Kanar HS et al (2020) Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial. Indian J Ophthalmol 68(1):145–151PubMedCrossRef
17.
Friberg TR, Karatza EC (1997) The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 104(12):2030–2038PubMedCrossRef
18.
Vujosevic S et al (2015) Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: Morphologic and Functional Safety. Retina 35(8):1594–1603
19.
Yu AK et al (2013) The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina. Invest Ophthalmol Vis Sci 54(3):2216–2224PubMedCrossRef
20.
Stanga PE, Reck AC, Hamilton AM (1999) Micropulse laser in the treatment of diabetic macular edema. Semin Ophthalmol 14(4):210–213PubMedCrossRef
21.
Venkatesh P et al (2011) Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed Laser Surg 29(11):727–733PubMedCrossRef
22.
Chen G et al (2016) Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina 36(11):2059–2065PubMedCrossRef
23.
Dorin G (2003) Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 18(3):147–153PubMedCrossRef
24.
25.
Chen SN et al (2008) Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115(12):2229–2234PubMedCrossRef
26.
Olk RJ et al (1999) Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 106(11):2082–2090PubMedCrossRef
27.
Parodi MB et al (2006) Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 113(12):2237–2242PubMedCrossRef
28.
29.
Funatsu H et al (2009) Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116(1):73–79PubMedCrossRef
30.
Jonas JB et al (2012) Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina 32(10):2150–2157PubMedCrossRef
31.
Midena E et al (2020) Changes of aqueous humor muller cells’ biomarkers in human patients affected by diabetic macular edema after subthreshold micropulse laser treatment. Retina 40(1):126–134PubMedCrossRef
32.
Elhamid A (2017) Combined intravitreal dexamethasone implant and micropulse yellow laser for treatment of anti-VEGF resistant diabetic macular edema. Open Ophthalmol J 11:164–172PubMedPubMedCentralCrossRef
33.
Valera-Cornejo DA et al (2021) Micropulse laser in patients with refractory and treatment-naive center-involved diabetic macular edema: short terms visual and anatomic outcomes. Ther Adv Ophthalmol 13:2515841420979112PubMedPubMedCentral
34.
Frizziero L, Calciati A, Midena G, Torresin T, Parrozzani R, Pilotto E, Midena E (2021) Subthreshold micropulse laser modulates retinal neuroinflammatory biomarkers in diabetic macular edema. J Clin Med 10(14):3134PubMedPubMedCentralCrossRef
35.
Vujosevic S et al (2015) Aqueous humor biomarkers of muller cell activation in diabetic eyes. Invest Ophthalmol Vis Sci 56(6):3913–3918PubMedCrossRef
36.
Karlstetter M et al (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30–57PubMedCrossRef
37.
Sarthy V (2007) Focus on molecules: glial fibrillary acidic protein (GFAP). Exp Eye Res 84(3):381–382PubMedCrossRef
38.
Midena E et al (2019) Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema. Sci Rep 9(1):10034ADSPubMedPubMedCentralCrossRef
39.
Vujosevic S et al (2018) Single retinal layer changes after subthreshold micropulse yellow laser in diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 49(11):e218–e225PubMedCrossRef
40.
Vujosevic S et al (2020) Optical coherence tomography angiography changes after subthreshold micropulse yellow laser in diabetic macular edema. Retina 40(2):312–321PubMedCrossRef
41.
Vujosevic S et al (2013) Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res 2013:491835PubMedPubMedCentralCrossRef
42.
Parravano M et al (2017) Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection. Am J Ophthalmol 179:90–96PubMedCrossRef
43.
Das A, McGuire PG, Rangasamy S (2015) Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122(7):1375–1394PubMedCrossRef
44.
45.
Bougatsou P et al (2020) Comparison of subthreshold 532 nm diode micropulse laser with conventional laser photocoagulation in the treatment of non-centre involved clinically significant diabetic macular edema. Acta Medica (Hradec Kralove) 63(1):25–30PubMedCrossRef
46.
Figueira J et al (2009) Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 93(10):1341–1344PubMedCrossRef
47.
Qiao G et al (2016) Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: a meta-analysis of randomized controlled trials. Int J Ophthalmol 9(7):1020–1027PubMedPubMedCentral
48.
Fazel F et al (2016) Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema. J Curr Ophthalmol 28(4):206–211PubMedPubMedCentralCrossRef
49.
Lois N et al (2023) Diabetic macular edema and diode subthreshold micropulse laser: a randomized double-masked noninferiority clinical trial. Ophthalmology 130(1):14–27PubMedCrossRef
50.
51.
Nicolo M, Musetti D, Traverso CE (2014) Yellow micropulse laser in diabetic macular edema: a short-term pilot study. Eur J Ophthalmol 24(6):885–889PubMedCrossRef
52.
Bahrami B et al (2017) Anti-VEGF therapy for diabetic eye diseases. Asia Pac J Ophthalmol (Phila) 6(6):535–545MathSciNetPubMed
53.
Abdelrahman A et al (2020) Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema. Int J Retina Vitreous 6(1):63PubMedPubMedCentralCrossRef
54.
Lai F et al (2021) Comparison of two-year treatment outcomes between subthreshold micropulse (577 nm) laser and aflibercept for diabetic macular edema. Jpn J Ophthalmol 65(5):680–688PubMedCrossRef
55.
Akkaya S et al (2020) Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity. Int J Ophthalmol 13(10):1606–1611PubMedPubMedCentralCrossRef
56.
Nakamura Y et al (2010) Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye (Lond) 24(5):784–788PubMedCrossRef
57.
Lavinsky D et al (2011) Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci 52(7):4314–4323PubMedCrossRef
58.
Luttrull JK, Spink CJ (2006) Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg Lasers Imaging 37(5):370–377PubMedCrossRef
59.
Okada K et al (2006) Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond) 20(7):805–809PubMedCrossRef
60.
Vujosevic S et al (2010) Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30(6):908–916PubMedCrossRef
61.
Mansouri A et al (2014) Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness. Eye (Lond) 28(12):1418–1424PubMedCrossRef
62.
Kim M et al (2020) The efficacy of selective retina therapy for diabetic macular edema based on pretreatment central foveal thickness. Lasers Med Sci 35(8):1781–1790PubMedCrossRef
63.
Singh A, Stewart JM (2009) Pathophysiology of diabetic macular edema. Int Ophthalmol Clin 49(2):1–11PubMedCrossRef
64.
Ozdemir H, Karacorlu M, Karacorlu S (2005) Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand 83(1):63–66PubMedCrossRef
65.
Wang XN et al (2018) The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy. Int J Ophthalmol 11(12):1957–1962PubMedPubMedCentral
66.
Boynton GE et al (2015) Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure. Ophthalmology 122(5):957–967PubMedCrossRef
67.
Isik MU, Degirmenci M, Saglik A (2022) Factors affecting the response to subthreshold micropulse laser therapy used in center-involved diabetic macular edema. Lasers Med Sci 37(3):1865–1871PubMedCrossRef
68.
Matsuda S et al (2014) The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema. J Diabetes Complicat 28(2):166–170CrossRef
69.
Donati MC et al (2021) Subthreshold yellow micropulse laser for treatment of diabetic macular edema: Comparison between fixed and variable treatment regimen. Eur J Ophthalmol 31(3):1254–1260PubMedCrossRef
70.
Luttrull JK, Musch DC, Mainster MA (2005) Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 89(1):74–80PubMedPubMedCentralCrossRef
71.
Chang DB, Luttrull JK (2020) Comparison of subthreshold 577 and 810 nm micropulse laser effects on heat-shock protein activation kinetics: implications for treatment efficacy and safety. Transl Vis Sci Technol 9(5):23PubMedPubMedCentralCrossRef
72.
Luttrull JK et al (2012) Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 32(2):375–386PubMedCrossRef
73.
Luttrull JK, Dorin G (2012) Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev 8(4):274–284PubMedPubMedCentralCrossRef
74.
Al-Barki A et al (2021) Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema. Sci Rep 11(1):14PubMedPubMedCentralCrossRef
75.
Sivaprasad S, Dorin G (2012) Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema. Expert Rev Med Devices 9(2):189–197PubMedCrossRef
76.
Abouhussein MA, Gomaa AR (2020) Aflibercept plus micropulse laser versus aflibercept monotherapy for diabetic macular edema: 1-year results of a randomized clinical trial. Int Ophthalmol 40(5):1147–1154PubMedCrossRef
77.
Kikushima W, Shijo T, Furuhata Y, Sakurada Y, Kashiwagi K (2021) Comparison of the 1-year visual and anatomical outcomes between subthreshold red (670 nm) and yellow (577 nm) micro-pulse laser treatment for diabetic macular edema. Pharmaceuticals 14(11):1100PubMedPubMedCentralCrossRef
78.
Khattab AM et al (2019) Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 257(7):1373–1380PubMedCrossRef
79.
Altinel MG et al (2021) Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema. Lasers Med Sci 36(7):1545–1553PubMedCrossRef
80.
Furashova O et al (2020) Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial. BMC Ophthalmol 20(1):308PubMedPubMedCentralCrossRef
81.
El ML et al (2021) Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up. Ther Adv Ophthalmol 13:25158414211040890
82.
Moisseiev E et al (2018) Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema. Eur J Ophthalmol 28(1):68–73PubMedCrossRef
83.
Inagaki K, Hamada M, Ohkoshi K (2019) Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema. Sci Rep 9(1):7585ADSPubMedPubMedCentralCrossRef
84.
Gawęcki M (2021) Subthreshold diode micropulse laser combined with intravitreal therapy for macular edema—a systematized review and critical approach. J Clin Med 10(7):1394PubMedPubMedCentralCrossRef
85.
86.
Luttrull JK, Sinclair SH (2014) Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity. Retina 34(10):2010–2020PubMedCrossRef
87.
Schatz H et al (1991) Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109(11):1549–1551PubMedCrossRef
88.
Maeshima K et al (2004) Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 24(4):507–511PubMedCrossRef
89.
Wells-Gray EM et al (2018) Structural integrity of individual cone photoreceptors after short-wavelength subthreshold micropulse laser therapy for diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 49(12):946–954PubMedPubMedCentralCrossRef
90.
91.
Vujosevic S et al (2013) Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues. Curr Med Chem 20(26):3267–3271PubMedCrossRef
92.
93.
94.
Hamada M et al (2018) Subthreshold photocoagulation using endpoint management in the PASCAL(R) system for diffuse diabetic macular edema. J Ophthalmol 2018:7465794PubMedPubMedCentralCrossRef
Metadata
Title
Subthreshold micropulse diode laser treatment in diabetic macular edema: biological impact, therapeutic effects, and safety
Authors
Jing Hao Mei
Zhong Lin
Publication date
01-12-2024
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 1/2024
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-02973-6

Other articles of this Issue 1/2024

International Ophthalmology 1/2024 Go to the issue

Original Paper

Imaging characterization of the fellow eye in patients with unilateral polypoidal choroidal vasculopathy

Original Paper

The effect of transepithelial corneal collagen cross-linking treatment on optical quality of the cornea in keratoconus: 12-month clinical results

Original Paper

Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases

Original Paper

Association between metformin use and the risk of developing open-angle glaucoma among patients with diabetes: a retrospective cohort study and meta-analysis

Original Paper

Outcomes after corneal crosslinking treatment in paediatric patients with keratoconus

Original Paper

PD protects Müller cells through the SIRT1/NLRP3 inflammasome pathway